1. Home
  2. ATLO vs HUMA Comparison

ATLO vs HUMA Comparison

Compare ATLO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$24.20

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.05

Market Cap

182.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
HUMA
Founded
1903
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
182.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATLO
HUMA
Price
$24.20
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.00
AVG Volume (30 Days)
23.1K
5.5M
Earning Date
01-23-2026
11-12-2025
Dividend Yield
3.27%
N/A
EPS Growth
82.57
N/A
EPS
1.80
N/A
Revenue
$60,568,000.00
$1,571,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$731.05
P/E Ratio
$13.63
N/A
Revenue Growth
18.60
N/A
52 Week Low
$16.09
$0.91
52 Week High
$24.96
$4.85

Technical Indicators

Market Signals
Indicator
ATLO
HUMA
Relative Strength Index (RSI) 63.47 45.11
Support Level $23.16 $0.96
Resistance Level $24.96 $1.15
Average True Range (ATR) 0.60 0.09
MACD 0.08 0.00
Stochastic Oscillator 64.60 33.20

Price Performance

Historical Comparison
ATLO
HUMA

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: